Table 3. Binary and multivariable logistic regression of variables associated with psychological need domain among oncology patients at DRH, Dessie, Ethiopia, 2020.
| Variables | Psychological need | ||||
|---|---|---|---|---|---|
| No need | Some need | COR (CI) | AOR (CI) | p value | |
| Age | 1.04 (1.02–1.06) | 1.02 (1.01–1.03–1.09) | <0.001 | ||
| Sex | |||||
| Female | 217 (66.2) | 58 (75.3) | 1 | 1 | |
| Male | 111 (33.8) | 19 (24.7) | 1.56 (0.88–2.75) | 0.96 (0.46–1.98) | 0.123 |
| Educational status | |||||
| Unable to read and write | 36 (46.8) | 175 (53.4) | 1 | 1 | |
| Primary education | 29 (37.7) | 68 (20.7) | 0.48 (0.28–0.84) | 0.73 (0.34–1.56) | 0.071 |
| Secondary education | 6 (7.8) | 40 (12.2) | 1.37 (0.54–3.47) | 2.12 (0.59–7.53) | 0.506 |
| College and above | 6 (7.8) | 45 (13.7) | 1.54 (0.61–3.89) | 1.72 (0.39–7.51) | 0.358 |
| Household monthly income | |||||
| 0–1,500 | 36 (46.8) | 119 (36.3) | 1 | 1 | |
| 1,501–2000 | 20 (26.0) | 71 (21.6) | 1.07 (0.58–1.99) | 1.37 (0.63–2.97) | 0.822 |
| 2,001–2,700 | 6 (7.8) | 54 (16.5) | 2.7 (1.08–6.84) | 2.23 (0.75–6.63) | 0.077 |
| >2,700 | 15 (19.5) | 84 (25.6) | 1.69 (0.87–3.29) | 1.4 (0.49–4.03) | 0.120 |
| Health insurance | |||||
| Yes | 52 (67.5) | 181 (55.2) | 1 | 1 | |
| No | 25 (32.5) | 147 (44.8) | 0.59 (0.35–1.00) | 1.08 (0.55–2.09) | 0.592 |
| Source of information | |||||
| Physician | 50 (64.9) | 191 (58.2) | 1 | 1 | |
| Physician and reading | 13 (16.9) | 85 (25.9) | 1.71 (0.88–3.31) | 2.61 (1.15–5.93) | 0.011a |
| Cancer site | |||||
| Breast | 39 (50.6) | 99 (30.2) | 1 | 1 | |
| Colon | 3 (3.9) | 36 (11.0) | 4.7 (1.37–16.25) | 1.86 (0.48–7.23) | 0.064 |
| Prostate | 2 (2.6) | 34 (10.4) | 6.6 (1.53–29.22) | 7.17 (1.3–39.6) | 0.011a |
| Lung | 5 (6.5) | 32 (9.8) | 2.56 (0.91–6.94) | 1.29 (0.39–4.22) | 0.074 |
| Skin | 4 (5.2) | 26 (7.9) | 2.56 (0.84–7.81) | 1.86 (0.52–6.63) | 0.099 |
| Cervical | 14 (18.2) | 69 (21.0) | 1.94 (0.98–3.85) | 1.05 (0.44-2.5) | 0.057 |
| Lipoma | 10 (13.0) | 32 (9.8) | 1.26 (0.56–2.81) | 0.76 (0.27–2.13) | 0.571 |
| Treatment option | |||||
| Chemotherapy | 53 (68.8) | 187 (57.0) | 1 | 1 | |
| Surgery | 10 (13.0) | 74 (22.6) | 2.09 (1.01–4.34) | 2.18 (0.92–5.21) | 0.046 |
| Analgesia | 14 (18.2) | 67 (20.4) | 1.35 (0.71–2.6) | 0.43 (0.18–4.57) | 0.359 |
| Cancer stage | |||||
| Early stage (I, II) | 30 (39.0) | 70 (21.3) | 1 | 1 | |
| Late stage (III, IV) | 47 (61.0) | 258 (78.7) | 2.35 (1.38–3.99) | 2.32 (1.18–4.57) | 0.023a |
| Recurrence | |||||
| No | 1 (1.3) | 17 (5.2) | 1 | 1 | |
| Yes | 76 (98.7) | 311 (94.8) | 0.24 (0.03–1.83) | 0.3 (0.032–2.95) | |
| Time since diagnosis | 0.98 (0.96–1.00) | 0.98 (0.95–1.01) | 0.067 | ||
| Remission | |||||
| No | 10 (13.0) | 159 (48.5) | 1 | 1 | |
| Yes | 67 (87.0) | 169 (51.5) | 0.16 (0.08–0.32) | 0.089 (0.036–0.22) | <0.001a |
COR, Crude odds ratio; AOR, Adjusted odds ratio; CI, Confidence interval
a
Statistically significant at p < 0.05